BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND TNFAIP3, TNFA1P2, 7128, ENSG00000118503, OTUD7C, MGC138687, MGC104522, A20, MGC138688, P21580
39 results:

  • 1. Novel high-resolution contrast agent ultrasound techniques HiFR CEUS and SR CEUS in combination with shear wave elastography, fat assessment and viscosity of liver parenchymal changes and tumors.
    Jung EM; Kaiser U; Herr W; Stroszczynski C; Jung F
    Clin Hemorheol Microcirc; 2024; 86(3):263-273. PubMed ID: 38489171
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Single-cell landscape of immune cells during the progression from HBV infection to HBV cirrhosis and HBV-associated hepatocellular carcinoma.
    Bai Q; Li R; He X; Hong X; Yan Y; Zhao Z; Lin H; Tacke F; Engelmann C; Hu T
    Front Immunol; 2023; 14():1320414. PubMed ID: 38116005
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Similar efficacy and safety between lenvatinib versus atezolizumab plus bevacizumab as the first-line treatment for unresectable hepatocellular carcinoma.
    Su CW; Teng W; Lin PT; Jeng WJ; Chen KA; Hsieh YC; Chen WT; Ho MM; Hsieh CH; Wang CT; Chai PM; Lin CC; Lin CY; Lin SM
    Cancer Med; 2023 Mar; 12(6):7077-7089. PubMed ID: 36468578
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. a20 interacts with mTORC2 to inhibit the mTORC2/Akt/Rac1 signaling axis in hepatocellular carcinoma cells.
    Wang X; Xiao Y; Dong Y; Wang Z; Yi J; Wang J; Wang X; Zhou H; Zhang L; Shi Y
    Cancer Gene Ther; 2023 Mar; 30(3):424-436. PubMed ID: 36411371
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Differential Engraftment of Parental a20 PD-L1 WT and PD-L1 KO Leukemia Cells in Semiallogeneic Recipients in the Context of PD-L1/PD-1 Interaction and NK Cell-Mediated Hybrid Resistance.
    Del Rio ML; Perez-Simon JA; Rodriguez-Barbosa JI
    Front Immunol; 2022; 13():887348. PubMed ID: 35795681
    [TBL] [Abstract] [Full Text] [Related]  

  • 6.
    Fan L; Liao W; Chen Z; Li S; Yang A; Chen MM; Liu H; Liu F
    Aging (Albany NY); 2022 May; 14(9):3801-3812. PubMed ID: 35504024
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Long Non-Coding RNAs Involved in Progression of Non-Alcoholic Fatty liver Disease to Steatohepatitis.
    Atanasovska B; Rensen SS; Marsman G; Shiri-Sverdlov R; Withoff S; Kuipers F; Wijmenga C; van de Sluis B; Fu J
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440652
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Gene signatures and potential therapeutic targets of Middle East respiratory syndrome coronavirus (MERS-CoV)-infected human lung adenocarcinoma epithelial cells.
    Wu YH; Yeh IJ; Phan NN; Yen MC; Hung JH; Chiao CC; Chen CF; Sun Z; Hsu HP; Wang CY; Lai MD
    J Microbiol Immunol Infect; 2021 Oct; 54(5):845-857. PubMed ID: 34176764
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Resolving the graft ischemia-reperfusion injury during liver transplantation at the single cell resolution.
    Wang L; Li J; He S; Liu Y; Chen H; He S; Yin M; Zou D; Chen S; Luo T; Yu X; Wan X; Huang S; Guo Z; He X
    Cell Death Dis; 2021 Jun; 12(6):589. PubMed ID: 34103479
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Efficient Intravenous Tumor Targeting Using the αvβ6 Integrin-Selective Precision Virotherapy Ad5
    Davies JA; Marlow G; Uusi-Kerttula HK; Seaton G; Piggott L; Badder LM; Clarkson RWE; Chester JD; Parker AL
    Viruses; 2021 May; 13(5):. PubMed ID: 34066836
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Hepatocellular carcinoma incidence post direct-acting antivirals in hepatitis C-related advanced fibrosis/cirrhosis patients in Australia.
    Chan PPY; Levy MT; Shackel N; Davison SA; Prakoso E
    Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):541-546. PubMed ID: 32660841
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The hepatotoxic fluoroquinolone trovafloxacin disturbs TNF- and LPS-induced p65 nuclear translocation in vivo and in vitro.
    Giustarini G; Huppelschoten S; Barra M; Oppelt A; Wagenaar L; Weaver RJ; Bol-Schoenmakers M; Smit JJ; van de Water B; Klingmüller U; Pieters RHH
    Toxicol Appl Pharmacol; 2020 Mar; 391():114915. PubMed ID: 32035082
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. a20 targets PFKL and glycolysis to inhibit the progression of hepatocellular carcinoma.
    Feng Y; Zhang Y; Cai Y; Liu R; Lu M; Li T; Fu Y; Guo M; Huang H; Ou Y; Chen Y
    Cell Death Dis; 2020 Feb; 11(2):89. PubMed ID: 32015333
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A Family With a20 Haploinsufficiency Presenting With Novel Clinical Manifestations and Challenges for Treatment.
    Hautala T; Vähäsalo P; Kuismin O; Keskitalo S; Rajamäki K; Väänänen A; Simojoki M; Säily M; Pelkonen I; Tokola H; Mäkinen M; Kaarteenaho R; Jartti A; Hautala N; Kantola S; Jackson P; Glumoff V; Saarela J; Varjosalo M; Eklund KK; Seppänen MRJ
    J Clin Rheumatol; 2021 Dec; 27(8):e583-e587. PubMed ID: 31977656
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Emerging role of zinc finger protein a20 as a suppressor of hepatocellular carcinoma.
    Yi PS; Shu Y; Bi WX; Zheng XB; Feng WJ; He LY; Li JS
    J Cell Physiol; 2019 Dec; 234(12):21479-21484. PubMed ID: 31134613
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Intratumoral delivery of antigen with complement C3-bound liposomes reduces tumor growth in mice.
    Francian A; Namen S; Stanley M; Mann K; Martinson H; Kullberg M
    Nanomedicine; 2019 Jun; 18():326-335. PubMed ID: 30419362
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Effect of a20 gene induced silencing on the biological behaviors of human nasopharyngeal carcinoma cell].
    Liu F; Xie WB; Zhou LY; Liu YH; Fang WY; Yao KT
    Zhonghua Yi Xue Za Zhi; 2018 Jun; 98(24):1956-1961. PubMed ID: 29996290
    [No Abstract]    [Full Text] [Related]  

  • 18. Ad5
    Uusi-Kerttula H; Davies JA; Thompson JM; Wongthida P; Evgin L; Shim KG; Bradshaw A; Baker AT; Rizkallah PJ; Jones R; Hanna L; Hudson E; Vile RG; Chester JD; Parker AL
    Clin Cancer Res; 2018 Sep; 24(17):4215-4224. PubMed ID: 29798908
    [No Abstract]    [Full Text] [Related]  

  • 19. Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells.
    Kalimuthu K; Lubin BC; Bazylevich A; Gellerman G; Shpilberg O; Luboshits G; Firer MA
    J Nanobiotechnology; 2018 Mar; 16(1):34. PubMed ID: 29602308
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Effects of DLC1 Deficiency on Endothelial Cell Contact Growth Inhibition and Angiosarcoma Progression.
    Sánchez-Martín D; Otsuka A; Kabashima K; Ha T; Wang D; Qian X; Lowy DR; Tosato G
    J Natl Cancer Inst; 2018 Apr; 110(4):390-399. PubMed ID: 29202196
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.